Neuropsychologic assessment of patients for movement disorder surgery

Movement Disorders

Volumn 15, Issue 5, 2000, Pages 771-783

  Angelini, Lucia ^a   Nardocci, Nardo ^a   Estienne, Margherita ^a   Conti, Chiara ^a   Dones, Ivano ^a   Broggi, Giovanni ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Assessment; Basal ganglia; Movement disorders; Neuropsychology; Neurosurgery; Parkinson's disease

Indexed keywords

ADULT; AGING; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; CLINICAL PRACTICE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; HUMAN; MEDICAL ASSESSMENT; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; NEUROSURGERY; PARKINSON DISEASE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PSYCHODYNAMICS; REVIEW; RISK ASSESSMENT; STAGING; SUBTHALAMIC NUCLEUS; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AFFECT; ATTENTION; BASAL GANGLIA; COGNITION DISORDERS; DEMENTIA; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; ELECTRIC STIMULATION THERAPY; HUMAN; MEMORY; MENTAL DISORDERS; MOTOR SKILLS; MOVEMENT DISORDERS; NEUROPSYCHOLOGICAL TESTS; NEUROSURGICAL PROCEDURES; PARKINSONIAN DISORDERS; PATIENT SELECTION; SUPPORT, NON-U.S. GOV'T;

EID: 0033819403     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200009)15:5<771::AID-MDS1003>3.0.CO;2-Y     Document Type: Review

References (134)

1. Cognitive function in Parkinson's disease: From description to theory
2. Cognitive deficits in Parkinson's disease
3. Frontal lobe dysfunction in Parkinson's disease: The cortical focus of neostriatal outflow
4. Depression in Parkinson's disease: A biochemical and organic viewpoint
5. Fronto-striatal cognitive deficits at different stages of Parkinson's disease
6. Neurocognitive deficits in Parkinson's disease
7. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients
8. Transient acute depression induced by high-frequency deep-brain stimulation
9. The impact of lesion laterality on neuropsychological change following posterior pallidotomy: A review of current findings
10. Posteroventral pallidotomy (PVP) in Parkinson's disease (PD). II: Effects on executive function and working memory
11. Subthalamic nucleus (STN) and globus pallidus (GPi) stimulation in Parkinson's disease. II: Effects on executive function and working memory
12. Cognitive and behavioural changes after unilateral posteroventral pallidotomy. Relationship with lesional data from MRI
13. Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease
14. Neuropsychological outcome of neurosurgical therapies in Parkinson's disease: A comparison of GPi pallidotomy and deep brain stimulation of GPi or STN
15. Impaired fronto-striatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease
16. Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease
17. Bilateral pallidotomy pronounced amelioration of incapacitating levodopa-induced dyskinesias but accompanying cognitive decline
18. Ablative therapy for movement disorders. Complications in the treatment of movement disorders
19. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures
20. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa
21. Parkinson's disease. Cognitive changes in relation to treatment response
22. Executive dysfunction and capacity to consent to treatment in Parkinson's disease
23. Posteroventral medial pallidotomy in Parkinson's disease
24. Parkinson's disease-second of two parts
25. Parkinson's disease-first of two parts
26. Conference participants. Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease (CAPSIT-PD)
27. Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism
28. Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration
29. Posteroventral medial pallidotomy in advanced Parkinson's disease
30. Preoperative indicators of clinical outcome following stereotaxic pallidotomy
31. A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: Identification of three distinct subtypes
32. Cognitive heterogeneity associated with clinical subtypes of Parkinson's disease
33. Frequency and cause of Parkinson's disease
34. Frequency of dementia in Parkinson disease
35. An estimate of the incidence of dementia in idiopathic Parkinson's disease
36. A brief assessment of frontal and subcortical functions in dementia
37. Mini-Mental Parkinson: First validation study of a new bedside test constructed for Parkinson's disease
38. Frontal behavioral inventory: Diagnostic criteria for frontal lobe dementia
39. A brief assessment of executive control dysfunction: Discriminant validity and homogeneity of planning, set shift, and fluency measures
40. The ability of the dementia rating scale to predict everyday functioning
41. Pathological correlates of dementia in Parkinson's disease
42. Non-Alzheimer degenerative dementias
43. Differential diagnosis of parkinsonism with [[18[F]fluorodeoxyglucose and PET
44. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal ganglionic degeneration
45. A clinicopathologic study of 100 cases of Parkinson's disease
46. Prevalence of dementia in Parkinson's disease
47. Noncognitive behavioral alterations in dementia syndromes
48. Memory and language in neurodegenerative diseases
49. Neuropsychological characteristics of preclinical dementia in Parkinson's disease
50. Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease
51. A review of Lewy body disease, an emerging concept of cortical dementia
52. Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease
53. Psychiatric manifestations and their predictive risk factors in Parkinson's disease
54. A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis
55. Depression, anxiety and hallucinations in Parkinson's disease
56. Parkinson's disease and anxiety: Comorbidity with depression
57. Dopaminomimetic psychosis in Parkinson's disease patients
58. Psychosis: Impact on the patient and family
59. Depression and Parkinson's disease: A review
60. Depression in Parkinson's disease: Impediments to recognition and treatment options
61. Cognitive functions in major depression and Parkinson's disease
62. Cognitive impairments and depression in Parkinson's disease: A follow up study
63. Depression in Parkinson's disease: A critical re-evaluation
64. Idiopathic Parkinson's disease: Revised concepts of cognitive and affective status
65. Neuropsychological impairment in Parkinson's disease with and without depression
66. A study of familial aggregation of depression, dementia and Parkinson's disease
67. Personality, depression, and premorbid lifestyle in twin pairs discordant for Parkinson's disease
68. Parkinson's disease and depression: Evidence for an alteration of the basal limbic system detected by transcranial sonography
69. Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson's disease
70. Depression in Parkinson's disease: A biochemical model
71. Obsessive-compulsive symptoms in Parkinson's disease
72. Depression: Impact and management by the patient and family
73. A controlled investigation of current and premorbid personality: Characteristics of Parkinson's disease patients
74. Personality correlates of [18F]dopa striatal uptake: Results of positron-emission tomography in Parkinson's disease
75. Neuropsychological aspects of Parkinson's disease and parkinsonism
76. The neuropsychology of Parkinson's disease
77. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodoparesponsive patients with Parkinson's disease with severe motor fluctuations: A 2-year follow-up review
78. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease
79. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
80. Unilateral pallidotomy for Parkinson's disease: Comparison of outcome in younger versus elderly patients
81. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients
82. Levodopa treatment may benefit or impair 'frontal' function in Parkinson's disease
83. L-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
84. L-Dopa and frontal cognitive function in Parkinson's disease
85. Unified Parkinson's disease rating scale
86. Performance with multiple sets in Parkinson's disease
87. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease
88. Effect of GPi pallidotomy on motor function in Parkinson's disease
89. The effect of unilateral posteroventral pallidotomy on the kinematics of the reach to grasp movement
90. Movement and reaction times and fine coordination tasks following pallidotomy
91. The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease
92. Outcomes assessment for pallidotomy
93. Pallidotomy technique and results: The New York University experience
94. Left posteroventral pallidotomy results in a deficit in verbal memory
95. Neuropsychological and behavioral changes and weight gain after medial pallidotomy
96. Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: A prospective randomized comparison
97. Neurocognitive and psychosocial correlates of ventroposterolateral pallidotomy surgery in Parkinson's disease
98. Hemisphere-specific cognitive and motor changes after unilateral posteroventral pallidotomy
99. Unilateral pallidal stimulation for Parkinson's disease: Neurobehavioral functioning before and 3 months after electrode implantation
100. Neuropsychological outcome following unilateral pallidotomy
101. 'Mini-Mental State.' A practical method for grading the cognitive state of patients for the clinician
102. A comparison of phonemic, semantic, and alternating word fluency in Parkinson's disease
103. Letter and semantic fluency in Alzheimer's, Huntington's, and Parkinson's dementias
104. Neuropsychological and motor functioning after unilateral anatomically guided posterior ventral pallidotomy. Preoperative performance and three-month follow-up
105. Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson's disease
106. Neuropsychological functioning before and after stereotactic ventroposterolateral pallidotomy in Parkinson's patients: Preliminary findings
107. Working memory in medicated patients with Parkinson's disease: The central executive seems to work
108. Cognitive processing speed affects both working memory and strategic memory in PD and normal aging
109. Paced auditory serial addition task: A measure of recovery from concussion
110. The Hopkins verbal leaning test: Development of a new memory test with six equivalent forms
111. Validity studies of the Hopkins verbal learning test-revised
112. The differential effects of cueing on recall in Parkinson's disease and normal subjects
113. Memory and learning in early Parkinson's disease: Evidence for a 'frontal lobe syndrome'
114. Prospective memory: A neuropsychological study
115. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions
116. The effect of Parkinson's disease on the ability to maintain a mental set
117. Procedural learning and neostriatal dysfunction in man
118. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
119. The behavioural and motor consequences of focal lesions of the basal ganglia in man
120. Frontal-subcortical circuits and human behavior
121. Cognitive and behavioral changes in patients with focal lesions of the basal ganglia
122. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: A review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases
123. Frontal-subcortical circuits and neuropsychiatric disorders
124. The psychology of perseverative and stereotyped behaviour
125. Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale
126. Frontal neuropsychiatric syndromes in Huntington's disease (HD) and Parkinson's disease (PD)
127. Treatment strategies for patients with dysexecutive syndromes
128. Diagnosis and treatment of patients with 'frontal lobe' syndromes